The nutraceutical industry has seen a great boom in the recent years as a result of the consumers seeking the convenient “healthful” solution in their diet. Amongst the various candidates of the nutraceutical world the everyday soybean has become a great nutraceutical today. In view of the importance gained by soybeans (Glycine max Family: Leguminosae) studies were carried out on the seeds of soybean. To evaluate its nutraceutical claims, antioxidant and anti-hyperlipidemic evaluations were carried out on the extracts obtained from the seeds of Glycine max. With an increase in the health reports relating free radicals and high lipid levels to an array of disease conditions, there has been a search for a safer solution from the nutraceutical world as a support to the conventional therapy. In the current study, the free radical scavenging activity was carried out using the DPPH method whereas the diet induced hyperlipidemia model in hamsters was used to evaluate the anti-hyperlipidemic activity. Both the studies yield results that support the current position of soybeans in the nutraceutical world.
Cite this article:
Manasi Nabar, Swati Patil. Glycine max: The Antioxidant and Anti-Hyperlipidemic Nutraceutical. Research J. Pharmacology and Pharmacodynamics. 2010; 2(5): 328-331.
Manasi Nabar, Swati Patil. Glycine max: The Antioxidant and Anti-Hyperlipidemic Nutraceutical. Research J. Pharmacology and Pharmacodynamics. 2010; 2(5): 328-331. Available on: https://rjppd.org/AbstractView.aspx?PID=2010-2-5-14